KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Xylem (XYL) EBIAT (2016 - 2025)

Xylem (XYL) has 16 years of EBIAT data on record, last reported at $340.0 million in Q4 2025.

  • For Q4 2025, EBIAT rose 4.29% year-over-year to $340.0 million; the TTM value through Dec 2025 reached $957.0 million, up 7.53%, while the annual FY2025 figure was $957.0 million, 7.53% up from the prior year.
  • EBIAT reached $340.0 million in Q4 2025 per XYL's latest filing, up from $222.0 million in the prior quarter.
  • Across five years, EBIAT topped out at $340.0 million in Q4 2025 and bottomed at $62.0 million in Q4 2022.
  • Average EBIAT over 5 years is $160.4 million, with a median of $133.0 million recorded in 2021.
  • Peak YoY movement for EBIAT: crashed 45.13% in 2022, then surged 329.03% in 2023.
  • A 5-year view of EBIAT shows it stood at $113.0 million in 2021, then tumbled by 45.13% to $62.0 million in 2022, then skyrocketed by 329.03% to $266.0 million in 2023, then increased by 22.56% to $326.0 million in 2024, then grew by 4.29% to $340.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were $340.0 million in Q4 2025, $222.0 million in Q3 2025, and $226.0 million in Q2 2025.